What are the CDC guidelines for neurocognitive assessment of patients with Duchenne muscular dystrophy (DMD)?

Updated: Aug 17, 2020
  • Author: Twee T Do, MD; Chief Editor: Jeffrey D Thomson, MD  more...
  • Print
Answer

Neurocognitive assessment recommendations are as follows:

  • Comprehensive developmental (in children ≤4 years old) or neuropsychological (in children ≥5 years old) assessment at or near time of diagnosis and before the start of formal schooling by a neuropsychologist or other professional with expertise in brain functioning and development, within the context of medical conditions
  • Standardized performance-based tests and parent/patient rating scales should be used

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!